Porous
Founded 2021 · 21 employees on LinkedIn · 1 known investors
POROUS develops a non-invasive, radiation-free 3D quantitative ultrasound (QUS) method to assess bone microstructure — including cortical thickness, pore size distribution, and viscoelasticity — for early detection and assessment of bone health conditions such as osteoporosis. Its technology serves clinical diagnostics and is also applied in animal breeding research to measure bone density and stability.
Investors · 1
Frequently asked questions
- What does Porous do?
- POROUS develops a non-invasive, radiation-free 3D quantitative ultrasound (QUS) method to assess bone microstructure — including cortical thickness, pore size distribution, and viscoelasticity — for early detection and assessment of bone health conditions such as osteoporosis. Its technology serves clinical diagnostics and is also applied in animal breeding research to measure bone density and stability.
- Who are Porous's investors?
- Porous's investors include NLC.